[Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
Laboratoires Servier, Fleury-les-Aubrais.
B
B
Lesobre
D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology / Q000517:prevention & control*; D001792:Blood Platelets / Q000187:drug effects; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000401:mortality / Q000503:physiopathology; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D004730:Endothelium, Vascular / Q000187:drug effects; D005342:Fibrinolysis; D005609:Free Radicals; D005907:Gliclazide / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D005609:Free Radicals; D013453:Sulfonylurea Compounds; D005907:Gliclazide
Macroangiopathie et diabète de type 2: intérêt du Diamicron.